PACK IN HAND · ONE-PAGE CHECK
Medicine pack check sheet
Print this sheet or fill it in before speaking with a pharmacist or clinician. Copy only what is printed on the pack in hand. The published fields below are starting points from this record, not proof that your pack is the same product.
Entries stay only in this open page and are not saved or sent.
Published record starting point
- Record display name
- Kaletra
- Generic name / active ingredient
- lopinavir and ritonavir
- Dosage-form class
- Dosage form and presentation as documented in the linked primary label
- Route
- Oral
- Record reviewed
- 2026-08-25
Copy from the pack in hand
Source-linked reading points
- KALETRA tablets and oral solution are not labelled in the same way; components, concentration, excipients, package and handling must be checked for the exact formulation, and tablets cannot be converted to millilitres by experience.
- The label carries extensive interaction clues. Prescription and OTC medicines, herbs, supplements, lipid medicines, antiarrhythmics, sedatives, anticoagulants and other anti-infectives require item-by-item review by an HIV/infectious-disease team or pharmacist.
- With jaundice-like changes, severe abdominal pain, rash or blistering, fainting/palpitations, marked weakness, fever or another acute concern, contact the treatment team promptly or use local urgent medical support.
Reviewed presentation examples — compare every field
- Per tablet: lopinavir 200 mg + ritonavir 50 mg; 120-tablet bottleNDC 0074-4014-12
- Per tablet: lopinavir 100 mg + ritonavir 25 mg; 60-tablet bottleNDC 0074-3008-60
- Per mL: lopinavir 80 mg + ritonavir 20 mg; 160 mL bottleNDC 0074-3956-46